Derivative exercise or conversion — not an open-market buy.
Traded Sep 2, 2026 · Filed Sep 3, 2026
Lam Research's Senior Vice President sold $8.01M of Lam Research shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$8,005,474
Shares × reported transaction price
35 days after results of Jul 29, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $288.32 on Sep 2, 2026, 195% above its 52-week low and 33% below its high, after a 10% drop over the previous 30 trading days
52-week range $97.74 (Sep 3, 2025) to $433.33 (Jun 30, 2026), 57% of the way up, from 252 adjusted closes. 30 trading days earlier: $319.29 on Jul 22, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -3.1% | -0.8% | -2.3% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
CEO sold ~$9.58M of Lam Research
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.